Anisodamine

DRUG3 trials

Sponsors

Jinhua Central Hospital, Sun Yat-sen University, Jie Chen

Conditions

Colorectal Cancer MetastaticNausea and VomitingSeptic Shock

Phase 1

Anisodamine Critically Ill SeptIc Shock

CompletedNCT02442440

Jinhua Central HospitalSeptic Shock

Start: 2015-04-30End: 2020-10-01Updated: 2021-09-29

Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation

CompletedNCT06045364

Jie ChenNausea and Vomiting

Start: 2023-10-01End: 2024-07-31Updated: 2024-09-05

Phase 2

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

RecruitingNCT05727163

Sun Yat-sen UniversityColorectal Cancer Metastatic

Start: 2022-07-29End: 2026-12-31Target: 194Updated: 2025-05-30

Related Papers

Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial

Critical Care2021-09-2725 citations

A phase III, multicenter randomized controlled trial of neo-adjuvant chemotherapy paclitaxel plus cisplatin versus surgery alone for stage IIA–IIIB esophageal squamous cell carcinoma

Journal of Thoracic Disease2017-01-0115 citations

Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study protocol for randomized controlled trial.

PubMed2015-10-019 citations